Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 94-8862 versus eplerenone in worsening chronic heart failure
NL-OMON40147Phase 2Active, not recruiting
- Sponsor
- Bayer
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone, eplerenone, sponsored by Bayer. Started Sep 2013; status: active, not recruiting.
02
Drugs
finerenoneeplerenone
Beyond the preview
Go deeper on NL-OMON40147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40147.